Get started
666

TWI BIOTECHNOLOGY INC

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

6610 chart


Full chart

Key stats


Market capitalization
‪1.17 B‬ TWD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.85 TWD
Net income (FY)
‪−170.68 M‬ TWD
Revenue (FY)
0.00 TWD
Shares float
‪23.60 M‬
Beta (1Y)
0.38

About TWI BIOTECHNOLOGY INC


Sector
Health Technology
CEO
Chu Chun Weng
Headquarters
Taipei
Website
twibiotech.com
Founded
2010
ISIN
TW0006610009
FIGI
BBG00FLZ6CS2
TWi Biotechnology, Inc. engages in the research and development of repositioned drugs for unmet medical needs, especially in rare diseases associated with innate immunity. The company was founded by Chih Ming Chen on July 16, 2010 and is headquartered in Taipei, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6610 is 13.60 TWD — it has increased by 3.76% in the past 24 hours. Watch TWI BIOTECHNOLOGY INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange TWI BIOTECHNOLOGY INC stocks are traded under the ticker 6610.
6610 stock has risen by 2.22% compared to the previous week, the month change is a 2.22% rise, over the last year TWI BIOTECHNOLOGY INC has showed a −15.26% decrease.
6610 reached its all-time high on Dec 27, 2016 with the price of 88.45 TWD, and its all-time low was 5.00 TWD and was reached on Mar 19, 2020. View more price dynamics on 6610 chart.
See other stocks reaching their highest and lowest prices.
6610 stock is 4.55% volatile and has beta coefficient of 0.38. Track TWI BIOTECHNOLOGY INC stock price on the chart and check out the list of the most volatile stocks — is TWI BIOTECHNOLOGY INC there?
Today TWI BIOTECHNOLOGY INC has the market capitalization of ‪1.21 B‬, it has increased by 3.76% over the last week.
Yes, you can track TWI BIOTECHNOLOGY INC financials in yearly and quarterly reports right on TradingView.
6610 net income for the last half-year is ‪−96.51 M‬ TWD, while the previous report showed ‪−130.01 M‬ TWD of net income which accounts for 25.77% change. Track more TWI BIOTECHNOLOGY INC financial stats to get the full picture.
No, 6610 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6610 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TWI BIOTECHNOLOGY INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TWI BIOTECHNOLOGY INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TWI BIOTECHNOLOGY INC stock shows the strong sell signal. See more of TWI BIOTECHNOLOGY INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.